Bisphosphonates	O
primarily	O
reduce	O
osteoclastic	O
activity	O
,	O
which	O
prevents	O
bonere	O
sorption	O
,	O
and	O
thus	O
moves	O
the	O
bone	O
resorption/formation	O
equilibrium	O
toward	O
the	O
formation	O
side	O
and	O
hence	O
makes	O
bone	O
stronger	O
on	O
the	O
long	O
run	O
.	O
Etidronate	O
,	O
unlike	O
other	O
bisphosphonates	O
,	O
also	O
prevents	O
bone	O
calcification	O
.	O
For	O
this	O
reason	O
,	O
other	O
bisphosphonates	O
,	O
like	O
alendronate	O
,	O
are	O
preferred	O
when	O
fightingosteoporosis	O
.	O
To	O
prevent	O
bone	O
resorption	O
without	O
affecting	O
too	O
much	O
bone	O
calcification	O
,	O
etidronate	O
must	O
be	O
administered	O
only	O
for	O
a	O
short	O
time	O
once	DATE
in	O
awhile	O
,	O
for	O
example	O
for	O
two	DURATION
weeks	DURATION
every	SET
3	SET
months	SET
.	O
When	O
given	O
on	O
a	O
continuous	O
basis	O
,	O
say	O
every	SET
day	SET
,	O
etidronate	O
will	O
altogether	O
prevent	O
bone	O
calcification	O
.	O
This	O
effect	O
may	O
be	O
useful	O
and	O
etidronate	O
is	O
in	O
fact	O
used	O
this	O
way	O
to	O
fightheterotopic	O
ossification	O
.	O
But	O
in	O
the	O
long	O
run	O
,	O
if	O
used	O
on	O
a	O
continuous	O
basis	O
,	O
it	O
will	O
cause	O
osteomalacia	O
.	O
